在急性髓性白血病中量身定制强化和低强化治疗
Carolin Seeling1, Arnold Ganser2, Hartmut Döhner1
1Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany.
Seminars in hematology
|October 15, 2025
概括
最近的进展已经改变了急性髓性白血病 (AML) 的治疗方法,包括新的向疗法和更新的欧洲白血病网 (ELN 2024) 风险分层,用于密集和不那么密集的方法.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 在过去的十年中,急性髓性白血病 (AML) 治疗取得了显著进展.
- 对AML生物学有了更深入的了解,从而改善了风险分层和向治疗.
研究的目的:
- 审查目前的AML前线治疗策略,包括密集和不那么密集的方法.
- 突出最近的治疗创新及其对AML管理的影响.
主要方法:
- 审查当前的科学文献和临床试验数据.
- 分析最近的欧洲白血病网 (ELN) 指南,包括ELN 2024风险分层.
主要成果:
- 新型向疗法已被批准用于特定的遗传AML亚组.
- ELN 2024提供了针对性药物的较少密集治疗的更新风险类别.
- 现有的ELN 2022类别不足以评估对新制度的反应.
结论:
- 在AML治疗的景观正在迅速发展,以机制为基础的治疗.
- 基于遗传特征的个性化治疗策略正在成为AML护理的标准.
- 持续的研究对于进一步优化AML患者的治疗结果至关重要.
更多相关视频
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
631
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
30.4K
相关概念视频
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
